Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ivar von Kügelgen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Anatomy
Living Beings
Disorders
Sign-in to see full Profile
Network (preview)
39
Starke, Klaus
12
Bültmann, Ralph
9
Molderings, Gerhard
9
Rump, Lars Christian
8
Driessen, Bernd
6
Illes, Peter
5
Meyer, A
5
Nörenberg, Wolfgang
4
Oberhauser, Vitus
4
Müller, Christa
4
Kolck, Ulrich
4
Göthert, Manfred
4
Allgaier, Clemens
3
Brüss, Michael
3
Homann, Jürgen
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ivar von Kügelgen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Pasternack Sandra M; von Kügelgen Ivar; Müller Melanie; Oji Vinzenz; Traupe Heiko; Sprecher Eli; Nöthen Markus M; Janecke Andreas R; Betz Regina C
In vitro analysis of LIPH mutations causing hypotrichosis simplex: evidence confirming the role of lipase H and lysophosphatidic acid in hair growth.
The Journal of investigative dermatology 2009;129(12):2772-6.
-
2009: Hoffmann Kristina; Baqi Younis; Morena María Sol; Glänzel Markus; Müller Christa E; von Kügelgen Ivar
Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor.
The Journal of pharmacology and experimental therapeutics 2009;331(2):648-55.
-
2009: Molderings Gerhard J; Solleder Gerold; Kolck Ulrich W; Homann Jürgen; Schröder Detlev; von Kügelgen Ivar; Vorreuther Roland
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.
Urological research 2009;37(4):227-9.
-
2009: Hillmann Petra; Ko Geun-Yung; Spinrath Andreas; Raulf Alexandra; von Kügelgen Ivar; Wolff Samuel C; Nicholas Robert A; Kostenis Evi; Höltje Hans-Dieter; Müller Christa E
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
Journal of medicinal chemistry 2009;52(9):2762-75.
-
2009: Alfter Kirsten; von Kügelgen Ivar; Haenisch Britta; Frieling Thomas; Hülsdonk Alexandra; Haars Ulrike; Rolfs Arndt; Noe Gerhard; Kolck Ulrich W; Homann Jürgen; Molderings Gerhard J
New aspects of liver abnormalities as part of the systemic mast cell activation syndrome.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(2):181-6.
-
2008: Haenisch Britta; von Kügelgen Ivar; Bönisch Heinz; Göthert Manfred; Sauerbruch Tilman; Schepke Michael; Marklein Günter; Höfling Katja; Schröder Detlev; Molderings Gerhard J
Regulatory mechanisms underlying agmatine homeostasis in humans.
American journal of physiology. Gastrointestinal and liver physiology 2008;295(5):G1104-10.
-
2008: Hoffmann Kristina; Sixel Uta; Di Pasquale Francesca; von Kügelgen Ivar
Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Biochemical pharmacology 2008;76(10):1201-13.
-
2008: Algaier I; Jakubowski J A; Asai F; von Kügelgen I
Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1908-14.
-
2008: Pasternack Sandra M; von Kügelgen Ivar; Aboud Khalid Al; Lee Young-Ae; Rüschendorf Franz; Voss Katrin; Hillmer Axel M; Molderings Gerhard J; Franz Thomas; Ramirez Alfredo; Nürnberg Peter; Nöthen Markus M; Betz Regina C
G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth.
Nature genetics 2008;40(3):329-34.
-
2008: von Kügelgen Ivar; Schiedel Anke C; Hoffmann Kristina; Alsdorf Bernt B A; Abdelrahman Aliaa; Müller Christa E
Cloning and functional expression of a novel Gi protein-coupled receptor for adenine from mouse brain.
Molecular pharmacology 2008;73(2):469-77.
-
2007: Molderings Gerhard J; Bönisch Heinz; Brüss Michael; Wolf Christiana; von Kügelgen Ivar; Göthert Manfred
S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.
Neurochemistry international 2007;51(8):476-85.
-
2007: Molderings Gerhard J; Göthert Manfred; von Kügelgen Ivar
Characterization of an antiproliferative effect of imidazoline receptor ligands on PC12 cells.
Pharmacological reports : PR 2007;59(6):789-94.
-
2007: Molderings Gerhard J; Kolck Ulrich W; Scheurlen Christian; Brüss Michael; Homann Jürgen; Von Kügelgen Ivar
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
Scandinavian journal of gastroenterology 2007;42(9):1045-53.
-
2007: Kolck Ulrich W; Alfter Kirsten; Homann Jürgen; von Kügelgen Ivar; Molderings Gerhard J
Cardiac mast cells: implications for heart failure.
Journal of the American College of Cardiology 2007;49(10):1107; author reply 1107-8.
-
2007: Wolf C; Brüss M; Hänisch B; Göthert M; von Kügelgen I; Molderings G J
Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.
Molecular pharmacology 2007;71(1):276-83.
-
2006: von Kügelgen Ivar
Excitatory P2-receptors at sympathetic axon terminals: role in temperature control of cutaneous blood flow.
British journal of pharmacology 2006;148(5):561-2.
-
2006: von Kügelgen Ivar
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
Pharmacology & therapeutics 2006;110(3):415-32.
-
2005: Gorzalka Simone; Vittori Sauro; Volpini Rosaria; Cristalli Gloria; von Kügelgen Ivar; Müller Christa E
Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues.
Molecular pharmacology 2005;67(3):955-64.
-
2004: Mamedova Liaman K; Joshi Bhalchandra V; Gao Zhan-Guo; von Kügelgen Ivar; Jacobson Kenneth A
Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors.
Biochemical pharmacology 2004;67(9):1763-70.
-
2003: Vonend Oliver; Grote Tobias; Oberhauser Vitus; Von Kügelgen Ivar; Rump Lars Christian
P2Y-receptors stimulating the proliferation of human mesangial cells through the MAPK42/44 pathway.
British journal of pharmacology 2003;139(6):1119-26.
-
2002: Kulick Melanie B; von Kügelgen Ivar
P2Y-receptors mediating an inhibition of the evoked entry of calcium through N-type calcium channels at neuronal processes.
The Journal of pharmacology and experimental therapeutics 2002;303(2):520-6.
-
2002: Vonend Oliver; Oberhauser Vitus; von Kügelgen Ivar; Apel Thomas W; Amann Kerstin; Ritz Eberhard; Rump Lars Christian
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells.
Kidney international 2002;61(5):1617-26.
-
2000: von Kügelgen I; Wetter A
Molecular pharmacology of P2Y-receptors.
Naunyn-Schmiedeberg's archives of pharmacology 2000;362(4-5):310-23.
-
2000: Nörenberg W; von Kügelgen I; Meyer A; Illes P; Starke K
M-type K+ currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release.
British journal of pharmacology 2000;129(4):709-23.
-
1999: Rump L C; Jabbari-T J; von Kügelgen I; Oberhauser V
Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors.
Journal of hypertension 1999;17(12 Pt 2):1987-93.
-
1999: von Kügelgen I; Nörenberg W; Meyer A; Illes P; Starke K
Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(5):360-9.
-
1999: Nörenberg W; von Kügelgen I; Meyer A; Illes P
Electrophysiological analysis of P2-receptor mechanisms in rat sympathetic neurones.
Progress in brain research 1999;120():209-21.
-
1999: von Kügelgen I; Nörenberg W; Koch H; Meyer A; Illes P; Starke K
P2-receptors controlling neurotransmitter release from postganglionic sympathetic neurones.
Progress in brain research 1999;120():173-82.
-
1999: Jacobson K A; Hoffmann C; Kim Y C; Camaioni E; Nandanan E; Jang S Y; Guo D P; Ji X D; von Kügelgen I; Moro S; Ziganshin A U; Rychkov A; King B F; Brown S G; Wildman S S; Burnstock G; Boyer J L; Mohanram A; Harden T K
Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis.
Progress in brain research 1999;120():119-32.
-
1999: Queiroz G; Meyer D K; Meyer A; Starke K; von Kügelgen I
A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors.
Neuroscience 1999;91(3):1171-81.
-
1998: Rump L C; Oberhauser V; von Kügelgen I
Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms.
Kidney international 1998;54(2):473-81.
-
1998: Koch H; von Kügelgen I; Starke K
P2-receptor-mediated inhibition of noradrenaline release in the rat pancreas.
Naunyn-Schmiedeberg's archives of pharmacology 1998;357(4):431-40.
-
1998: von Kügelgen I; Gonçalves J; Driessen B; Starke K
Corelease of noradrenaline and adenosine triphosphate from sympathetic neurones.
Advances in pharmacology (San Diego, Calif.) 1998;42():120-5.
-
1997: von Kügelgen I; Koch H; Starke K
P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.
Neuropharmacology 1997;36(9):1221-7.
-
1997: Bohmann C; von Kügelgen I; Rump L C
P2-receptor modulation of noradrenergic neurotransmission in rat kidney.
British journal of pharmacology 1997;121(7):1255-62.
-
1997: Koch H; von Kügelgen I; Starke K
P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(6):707-15.
-
1997: Queiroz G; Gebicke-Haerter P J; Schobert A; Starke K; von Kügelgen I
Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation.
Neuroscience 1997;78(4):1203-8.
-
1997: von Kügelgen I; Nörenberg W; Illes P; Schobert A; Starke K
Differences in the mode of stimulation of cultured rat sympathetic neurons between ATP and UDP.
Neuroscience 1997;78(4):935-41.
-
1996: von Kügelgen I; Stoffel D; Schobert A; Starke K
P2-purinoceptors on postganglionic sympathetic neurones.
Journal of autonomic pharmacology 1996;16(6):413-6.
-
1996: Rump L C; Bohmann C; Schwertfeger E; Krumme B; von Kügelgen I; Schollmeyer P
Extracellular ATP in the human kidney: mode of release and vascular effects.
Journal of autonomic pharmacology 1996;16(6):371-5.
-
1996: Starke K; von Kügelgen I; Driessen B; Bültmann R
ATP release and its prejunctional modulation.
Ciba Foundation symposium 1996;198():239-49; discussion 249-59.
-
1995: von Kügelgen I; Krumme B; Schaible U; Schollmeyer P J; Rump L C
Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels.
British journal of pharmacology 1995;116(2):1932-6.
-
1995: Gonçalves J; Driessen B; von Kügelgen I; Starke K
Comparison of corelease of noradrenaline and ATP evoked by hypogastric nerve stimulation and field stimulation in guinea-pig vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1995;352(2):229-35.
-
1995: Allgaier C; Wellmann H; Schobert A; Kurz G; von Kügelgen I
Cultured chick sympathetic neurons: ATP-induced noradrenaline release and its blockade by nicotinic receptor antagonists.
Naunyn-Schmiedeberg's archives of pharmacology 1995;352(1):25-30.
-
1995: Allgaier C; Wellmann H; Schobert A; von Kügelgen I
Cultured chick sympathetic neurons: modulation of electrically evoked noradrenaline release by P2-purinoceptors.
Naunyn-Schmiedeberg's archives of pharmacology 1995;352(1):17-24.
-
1995: Bohmann C; Rump L C; Schaible U; von Kügelgen I
Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats.
Hypertension 1995;25(6):1224-31.
-
1995: von Kügelgen I; Stoffel D; Starke K
P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
British journal of pharmacology 1995;115(2):247-54.
-
1994: Kurz A K; Bültmann R; Driessen B; von Kügelgen I; Starke K
Release of ATP in rat vas deferens: origin and role of calcium.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(5):491-8.
-
1994: Driessen B; von Kügelgen I; Bültmann R; Elrick D B; Cunnane T C; Starke K
The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(5):482-90.
-
1994: von Kügelgen I; Späth L; Starke K
Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
British journal of pharmacology 1994;113(3):815-22.
-
1994: von Kügelgen I; Starke K
Corelease of noradrenaline and ATP by brief pulse trains in guinea-pig vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(2):123-9.
-
1994: von Kügelgen I; Allgaier C; Schobert A; Starke K
Co-release of noradrenaline and ATP from cultured sympathetic neurons.
Neuroscience 1994;61(2):199-202.
-
1994: Driessen B; von Kügelgen I; Starke K
P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(1):42-8.
-
1994: Allgaier C; Pullmann F; Schobert A; Von Kügelgen I; Hertting G
P2 purinoceptors modulating noradrenaline release from sympathetic neurons in culture.
European journal of pharmacology 1994;252(2):R7-8.
-
1994: von Kügelgen I
Purinoceptors modulating the release of noradrenaline.
Journal of autonomic pharmacology 1994;14(1):11-2.
-
1994: von Kügelgen I; Kurz K; Starke K
P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1994;349(2):125-32.
-
1994: Rump L C; von Kügelgen I
A study of ATP as a sympathetic cotransmitter in human saphenous vein.
British journal of pharmacology 1994;111(1):65-72.
-
1994: von Kügelgen I; Kurz K; Bültmann R; Driessen B; Starke K
Presynaptic modulation of the release of the co-transmitters noradrenaline and ATP.
Fundamental & clinical pharmacology 1994;8(3):207-13.
-
1993: Kurz K; von Kügelgen I; Starke K
Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.
British journal of pharmacology 1993;110(4):1465-72.
-
1993: von Kügelgen I; Späth L; Starke K
Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices.
British journal of pharmacology 1993;110(4):1544-50.
-
1993: Driessen B; von Kügelgen I; Starke K
Neural ATP release and its alpha 2-adrenoceptor-mediated modulation in guinea-pig vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1993;348(4):358-66.
-
1993: von Kügelgen I; Kurz K; Starke K
Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release.
Neuroscience 1993;56(2):263-7.
-
1993: Bültmann R; von Kügelgen I; Starke K
Effects of nifedipine and ryanodine on adrenergic neurogenic contractions of rat vas deferens: evidence for a pulse-to-pulse change in Ca2+ sources.
British journal of pharmacology 1993;108(4):1062-70.
-
1993: Driessen B; Bültmann R; von Kügelgen I; Starke K
Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.
British journal of pharmacology 1993;108(2):443-7.
-
1992: von Kügelgen I; Späth L; Starke K
Adenosine but not an adenine nucleotide mediates tonic purinergic inhibition, as well as inhibition by glutamate, of noradrenaline release in rabbit brain cortex slices.
Naunyn-Schmiedeberg's archives of pharmacology 1992;346(6):677-84.
-
1992: von Kügelgen I; Späth L; Starke K
Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1992;346(2):187-96.
-
1992: Starke K; von Kügelgen I; Bültmann R
Noradrenaline-ATP cotransmission: operation in blood vessels and cotransmitter release ratios.
Japanese journal of pharmacology 1992;58 Suppl 2():166P-173P.
-
1991: von Kügelgen I; Starke K
Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(4):419-29.
-
1991: Bültmann R; von Kügelgen I; Starke K
Adrenergic and purinergic cotransmission in nicotine-evoked vasoconstriction in rabbit ileocolic arteries.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(2):174-82.
-
1991: Bültmann R; von Kügelgen I; Starke K
Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(6):623-32.
-
1991: Starke K; von Kügelgen I; Bulloch J M; Illes P
Nucleotides as cotransmitters in vascular sympathetic neuroeffector transmission.
Blood vessels 1991;28(1-3):19-26.
-
1991: Starke K; Bültmann R; Bulloch J M; von Kügelgen I
Noradrenaline-ATP corelease and cotransmission following activation of nicotine receptors at postganglionic sympathetic axons.
Journal of neural transmission. Supplementum 1991;34():93-8.
-
1990: von Kügelgen I; Bültmann R; Starke K
Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(2):198-205.
-
1990: von Kügelgen I; Starke K
Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.
Naunyn-Schmiedeberg's archives of pharmacology 1990;341(6):538-46.
-
1989: von Kügelgen I; Bültmann R; Starke K
Effects of suramin and alpha, beta-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(6 Pt 2):760-3.
-
1989: von Kügelgen I; Schöffel E; Starke K
Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(5):522-32.
-
1987: von Kügelgen I; Häussinger D; Starke K
Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.
Naunyn-Schmiedeberg's archives of pharmacology 1987;336(5):556-60.
Sign-in to see more
